celecoxib has been researched along with Bone Spur in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disease progression was monitored utilizing micro-magnetic resonance imaging (MRI), micro-computed tomography (CT) and histology." | 1.40 | Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties. ( Doschak, MR; Fallone, BG; Jaremko, JL; Lambert, RG; Maksymowych, WP; Panahifar, A; Tessier, AG, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hsia, AW | 1 |
| Jbeily, EH | 1 |
| Mendez, ME | 1 |
| Cunningham, HC | 1 |
| Biris, KK | 1 |
| Bang, H | 1 |
| Lee, CA | 1 |
| Loots, GG | 1 |
| Christiansen, BA | 1 |
| Tellegen, AR | 1 |
| Rudnik-Jansen, I | 1 |
| Pouran, B | 1 |
| de Visser, HM | 1 |
| Weinans, HH | 1 |
| Thomas, RE | 1 |
| Kik, MJL | 1 |
| Grinwis, GCM | 1 |
| Thies, JC | 1 |
| Woike, N | 1 |
| Mihov, G | 1 |
| Emans, PJ | 1 |
| Meij, BP | 1 |
| Creemers, LB | 1 |
| Tryfonidou, MA | 1 |
| Panahifar, A | 1 |
| Jaremko, JL | 1 |
| Tessier, AG | 1 |
| Lambert, RG | 1 |
| Maksymowych, WP | 1 |
| Fallone, BG | 1 |
| Doschak, MR | 1 |
3 other studies available for celecoxib and Bone Spur
| Article | Year |
|---|---|
Post-traumatic osteoarthritis progression is diminished by early mechanical unloading and anti-inflammatory treatment in mice.
Topics: Animals; Anterior Cruciate Ligament Injuries; Anti-Inflammatory Agents, Non-Steroidal; Cathepsins; C | 2021 |
Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis.
Topics: Animals; Anterior Cruciate Ligament; Biocompatible Materials; Bone and Bones; Celecoxib; Cyclooxygen | 2018 |
Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties.
Topics: Animals; Anterior Cruciate Ligament; Bone Cysts; Bone Marrow Diseases; Cartilage, Articular; Celecox | 2014 |